RENOCRIT RECOMBINANT INJECTION

Get a Price/Quote

RENOCRIT RECOMBINANT INJECTION Specification

Origin of Medicine
Biotechnological / Recombinant

Dosage Form
Injection

Pacakaging (Quantity Per Box)
1 Pre-filled Syringe/Box

Salt Composition
Erythropoietin Alfa

Indication
Anemia and Chronic Kidney Disease

Drug Type
Biological Product

Ingredients
Recombinant Human Erythropoietin Alfa

Physical Form
Liquid Solution

Function
Stimulates Red Blood Cell Production

Recommended For
Anemia Associated with Chronic Renal Failure

Dosage
As Directed by Physician

Dosage Guidelines
Administer as per doctors prescription. Not to be self-administered.

Suitable For
Adults

Quantity
1 Injection per Box

Storage Instructions
Store in Refrigerator (2C to 8C). Do not freeze.

Strength
4000 IU

Prescription Status
Prescription Only

Warnings
Not for use in patients with uncontrolled hypertension or known hypersensitivity to erythropoietin

Route of Administration
Intravenous (IV) or Subcutaneous

Shelf Life
24 Months

Common Side Effects
Hypertension, headache, injection site reaction

Appearance
Clear, Colorless Solution

Brand Name
RENOCRIT

RENOCRIT RECOMBINANT INJECTION Trade Information

Packaging Details
PACK OF 1 VIAL

Main Domestic Market
All India

About RENOCRIT RECOMBINANT INJECTION

Renocrit

Specifications:-

Brand Name :- RENOCRIT
Content:- Recombinant
Strength: 4000 IU
Form:- Injection
Packing:- 1 vial
Manufactured By :- Zydus

Note :- RENOCRIT Is A Prescription Drug And Should Be Used Under Proper Medical Guidance And Advice. Do Not Share The Medicine With Others, Since They May Be Suffering From A Problem That Is Not Effectively Treated By This Drug...............

Stimulates Red Blood Cell Production

RENOCrit Injection is designed to boost red blood cell formation in patients with chronic renal failure-related anemia. Thanks to its active ingredient, erythropoietin alfa, this biological product effectively addresses the underlying issues of reduced erythropoietin in chronic kidney disease, helping to restore optimal hemoglobin levels.

Biotechnological Origin for Enhanced Efficacy

Produced using advanced recombinant DNA technology, RENOCrit is a highly purified, consistent, and reliable solution for anemia management. Its biological origin ensures compatibility and minimizes the risk of immune responses, differentiating it from older treatments.

Safe Administration and Storage Guidelines

RENOCrit must be administered under the guidance of a healthcare professional, either intravenously or subcutaneously. It is important to keep the injection refrigerated (2C to 8C) and not frozen, ensuring the stability and effectiveness of the medication.

FAQs of RENOCRIT RECOMBINANT INJECTION:

Q: How should RENOCrit Injection be administered?

A: RENOCrit Injection must be administered by a healthcare professional, either intravenously (IV) or subcutaneously, as directed by your physician. It is not intended for self-administration.

Q: What is the recommended usage of RENOCrit and who can use it?

A: RENOCrit is recommended for adults with anemia associated with chronic renal failure. The dose and frequency are tailored to your specific needs by your doctor. It should not be used without medical supervision or by individuals with uncontrolled hypertension or a known allergy to erythropoietin.

Q: When is RENOCrit most beneficial for patients?

A: RENOCrit is especially beneficial for adults experiencing anemia due to chronic kidney disease, as it promotes the production of red blood cells that the diseased kidneys can no longer adequately produce.

Q: Where should RENOCrit Injection be stored before use?

A: RENOCrit should be stored in a refrigerator at temperatures between 2C and 8C. It must not be frozen or exposed to light. Always check the products shelf life and use before expiry.

Q: What are the common side effects of RENOCrit Injection?

A: Commonly reported side effects include hypertension, headache, and injection site reactions such as redness or discomfort. If you experience any severe or persistent symptoms, inform your healthcare provider immediately.

Q: What process does RENOCrit follow to treat anemia in chronic kidney disease?

A: RENOCrit contains recombinant erythropoietin alfa, which stimulates your bone marrow to produce more red blood cells, effectively addressing anemia due to reduced erythropoietin levels in chronic kidney disease.

Tell us about your requirement